Evidence map›Paper›PMID 34189320›Full record

ArticleHeliyon2021

Identifying and characterizing different stages toward Alzheimer's disease using ordered core features and machine learning.

Jinhua Sheng, Bocheng Wang, Qiao Zhang, Rougang Zhou, Luyun Wang, Yu Xin

Open access · goldAbstract read
In one paragraph

Article in Heliyon, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Alzheimer's disease plasma biomarkers and physical functioning in a diverse sample of adults.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Article
  3. Article
  4. Biological Activities and Nanoparticle Synthesis ofPharmaceutical nanotechnology · 2024
    Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Jinhua ShengCollege of Computer Science and Technology, Hangzhou Dianzi University, Hangzhou, Zhejiang, 310018, China.
Bocheng WangCollege of Computer Science and Technology, Hangzhou Dianzi University, Hangzhou, Zhejiang, 310018, China.
Qiao ZhangBeijing Hospital, Beijing, 100730, China.
Rougang ZhouKey Laboratory of Intelligent Image Analysis for Sensory and Cognitive Health, Ministry of Industry and Information Technology of China, Hangzhou, Zhejiang, 310018, China.
Luyun WangCollege of Computer Science and Technology, Hangzhou Dianzi University, Hangzhou, Zhejiang, 310018, China.
Yu XinCollege of Computer Science and Technology, Hangzhou Dianzi University, Hangzhou, Zhejiang, 310018, China.
Hangzhou Dianzi University · CNBeijing Hospital · CNCommunication University of Zhejiang · CNUstar Biotechnologies (China) · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Based on the joint HCPMMP parcellation method we developed before, which divides the cortical brain into 360 regions, the concept of ordered core features (OCF) is first proposed to reveal the functional brain connectivity relationship among different cohorts of Alzheimer's disease (AD), late mild cognitive impairment (LMCI), early mild cognitive impairment (EMCI) and healthy controls (HC). A set of core network features that change significantly under the specifically progressive relationship were extracted and used as supervised machine learning classifiers. The network nodes in this set mainly locate in the frontal lobe and insular, forming a narrow band, which are responsible for cognitive impairment as suggested by previous finding. By using these features, the accuracy ranged from 86.0% to 95.5% in binary classification between any pair of cohorts, higher than 70.1%-91.0% when using all network features. In multi-group classification, the average accuracy was 75% or 78% for HC, EMCI, LMCI or EMCI, LMCI, AD against baseline of 33%, and 53.3% for HC, EMCI, LMCI and AD against baseline of 25%. In addition, the recognition rate was lower when combining EMCI and LMCI patients into one group of mild cognitive impairment (MCI) for classification, suggesting that there exists a big difference between early and late MCI patients. This finding supports the EMCI/LMCI inclusion criteria introduced by ADNI based on neuropsychological assessments.

Indexed as

Alzheimer's disease (AD)Connectivity network analysisHuman connectome project (HCP)Machine learningMild cognitive impairment (MCI)The area under ROC curve (AUC)

Identifiers

PMID34189320
PMCPMC8220177
OpenAlexW3172097624

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.